Vadim I Mazurov

7PUBLICATIONS
105CO-AUTHORS
Disease surveillanceRheumatology and arthritisCancer therapy (excl. chemotherapy and radiation therapy)OrthopticsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 12, 2025
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA.

E L Nasonov, V I Mazurov, A M Lila

|Apr 16, 2025
[Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases].

G V Lukina, O V Knyazev, E A Belousova

|Jun 03, 2024
[Efficacy and safety of undenatured type II collagen in patients with knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial].

L I Alekseeva, N G Kashevarova, E A Taskina

|May 24, 2024
[Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D3 and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint].

V I Mazurov, I B Belyaeva, E A Trofimov

|Oct 26, 2022
[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial].

A D Kulagin, B A Bakirov, I L Davydkin

|Sep 29, 2021
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study.

Nikita V Lomakin, Bulat A Bakirov, Denis N Protsenko

Pageof 2

Frequent Collaborators

4 joint publications

Alexander M Lila

3 joint publications

Maria A Morozova

3 joint publications

Arina V Zinkina-Orikhan

3 joint publications

Yulia N Linkova